Clinical study on the use of low-dose cytosine arabinoside (Ara-C) in the treatment of myelodysplastic syndromes and acute myelogenous leukemia.
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute myelogenous leukemia.
CAZZOLA, MARIO;RICCARDI, ALBERTO
1987-01-01
Abstract
Clinical study on the use of low-dose cytosine arabinoside (Ara-C) in the treatment of myelodysplastic syndromes and acute myelogenous leukemia.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
